The Skeletal Dysplasia Market is expanding, driven by advancements in gene sequencing and orphan drug incentives. Key ...

FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the ...

Council brings together leading global scientific and clinical experts in metabolic diseases to guide development of Nxera’s ...

According to MarketsandMarkets™, the Al in Clinical Workflow Market is projected to grow from about USD 2.78 billion in 2025 ...

Among infants aged 90 days or younger who present to the emergency department (ED) or hospital with hypothermia, what is the prevalence of significant pathology, and what pathology is seen?

Please provide your email address to receive an email when new articles are posted on . Shared decision-making and survivorship were two areas of emphasis in the ATA’s 2025 thyroid cancer guideline.

Tempus AI has acquired the digital pathology developer Paige, including its FDA-cleared, artificial-intelligence-powered programs for spotting the signs of cancer. The deal totals $81.25 million, ...

Nicole A. Cipriani, MD, surgical pathologist at the University of Chicago Medicine, addresses the clinical relevance of the BRAF p.V600E mutation in risk stratification for patients with papillary ...

Endocrine disruptors are defined as substances, or mixtures of substances, that interfere with the function of the endocrine system. These chemicals can act at very low doses, often exert combined or ...

When these hormones become imbalanced, it can lead to the development of an endocrine disorder. “An endocrine disorder occurs when your body produces either too much or too little of a particular ...

Women receiving endocrine therapy for hormone receptor (HR)–positive breast cancer or its prevention among those at high risk for breast cancer commonly have vasomotor symptoms. Data are lacking on ...

Melad Dababneh, M.B.B.S., Assistant Professor, Anatomic Pathology, will serve as section head of Head and Neck Pathology, effective June 1. Dababneh joined the UAB Department of Pathology in 2024 from ...